CrushSCI.com
242.9平均天数
176中位天数
97最短天数
560最长天数
3572025发文量

Paper Review Records

全部论文审稿周期

15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

97 天

Targeting nucleolin-driven cancer stemness suppresses high-risk neuroblastoma in vivo

作者
Dan Qi; Ronghu Ke; Euni Wu; Yizhong Pan; S. Stephen Yi; Jason H. Huang; Erxi Wu展开收起
作者单位
Department of Neurosurgery and Neuroscience Institute, Baylor Scott & White Health, Temple, TX 76508, USA; Baylor Research Institute, Baylor Scott & White Health, Temple, TX 76508, USA; Department of Neurosurgery, Baylor College of Medicine, Temple, TX 76508, USA; Department of Electrical and Computer Engineering, Cockrell School of Engineering, The University of Texas at Austin, Austin, TX 78712, USA; Naresh K. Vashisht College of Medicine and Irma Lerma Rangel College of Pharmacy, Texas A&M University, College Station, TX 77843, USA; Cancer Research Center and Department of Internal Medicine, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA展开收起
PDF源文件 DOI 网页
306 天

ENO1 as a potential tumor prognostic marker promotes the proliferation, invasion, and metastasis of breast cancer cells

作者
Lifang He; Yue Xu; Lu Huang; Lijuan He; Zexiao Chen; Zhaochang Qi; Yukun Cui展开收起
作者单位
Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong 515063, China; Shantou Key Laboratory of Precision Diagnosis and Treatment in Women's Cancer, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong 515063, China; State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, Guangdong 511436, China; Guangzhou Morui Pharmaceutical Technology Co., Ltd., Guangzhou Medical University, Guangzhou, Guangdong 511436, China; Precision Oncology Diagnosis and Treatment Centre of Foshan Fosun Chancheng Hospital, Foshan, Guangdong 528031, China; Outpatient Nursing, Hangzhou West Lake Zhijiang Ophthalmology Hospital, Hangzhou, Zhejiang 310000, China展开收起
PDF源文件 DOI 网页
560 天

Ginsenoside Rg1 attenuates mitochondrial dysfunction in bleomycin-induced pulmonary fibrosis by inhibiting Nrf2/Sirt3 pathways

作者
Qi Qi; Shihao Wen; Linchao Niu; Ru Zhang; Meili Lu; Jingliang Zhang; Hongxin Wang展开收起
作者单位
Key Laboratory of Cardiovascular and Cerebrovascular Drug Research of Liaoning Province, Jinzhou Medical University, Jinzhou, Liaoning 121000, China; Department of Anesthesiology, Jinzhou Central Hospital, Jinzhou Medical University Graduate Training Base, Jinzhou, Liaoning 121000, China; Internal Medicine-Cardiovascular Department, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121000, China展开收起
PDF源文件 DOI 网页
131 天

A candidate PTPN5 frameshift variant in a family with a neurodevelopmental disorder supported by a zebrafish loss-of-function model

作者
Yunlong Meng; Yu Chen; Xingkun Tang; Kangyu Liu; YanLi Ma; Yuanhai Xie; Zilin Zhong; Jianjun Chen展开收起
作者单位
Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center for Anesthesiology and Perioperative Medicine, Translational Research Institute of Brain and Brain-Like Intelligence, Department of Pediatrics, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai 200434, China; Institute of Medical Genetics, Department of Big Data in Health Science, School of Public Health and General Medicine, Tongji University School of Medicine, Tongji University, Shanghai 200331, China展开收起
PDF源文件 DOI 网页
121 天

Genetic engineering of primary human mesenchymal stromal cells using the CRISPR/Cas9 synergistic activation mediator

作者
M.C. Killer; X. Zhang; T. Adhikary; C. Kasper; A. Neubauer; M. Frech; C. Brendel展开收起
作者单位
Department of Hematology, Oncology and Immunology, Marburg University, Marburg 35041, Germany; Department of Regenerative Medicine, Tongji University, Shanghai 200092, China; Institute of Molecular Biology and Tumor Research, Marburg University, Marburg 35041, Germany; Department for Biotechnology and Food Technology, BOKU University, Vienna 1180, Austria展开收起
PDF源文件 DOI 网页
176 天

Robust prediction of response to growth hormone therapy by five PBMC-based transcripts

作者
Valerie van Kekem; Irene Victoria Bermúdez-Pérez; Alexandra E. Kulle; Maik Welzel; Nadine Hornig; Gerhard Binder; Matthias Hübenthal; Robert Häsler; Paul-Martin Holterhus展开收起
作者单位
Department of Neurology, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel, Arnold-Heller-Straße 3, Kiel 24105, Germany; Department of Dermatology and Allergy, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel, Arnold-Heller-Straße 3, Kiel 24105, Germany; Department of Pediatrics I, Pediatric Endocrinology and Diabetes, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel, Kiel 24105, Germany; Institute of Clinical Chemistry, UKSH, Kiel/Lübeck 24105, Germany; Private Practice of Pediatrics, Am Ochsenkopf 1, Eckernförde 24340, Germany; Institute of Human Genetics, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel, Kiel 24105, Germany; Pediatric Endocrinology, University Children’s Hospital Tübingen, Tübingen 72076, Germany展开收起
PDF源文件 DOI 网页

FAQ

Genes & Diseases审稿要多久?

截至2026-11-19,CrushSCI 收录了 Genes & Diseases 的 15 篇完整审稿记录。最快一篇从收稿到录用用了 97 天(Targeting nucleolin-driven cancer stemness suppresses high-risk neuroblastoma in vivo,2026-01-21 收稿,2026-04-28 录用),最慢一篇用了 560 天;平均 242.9 天,中位数 176 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。